- About EAS
EAS Consensus Position Paper Initiative
The EAS Consensus Panel, comprised of internationally renowned experts in atherosclerosis and cardiovascular disease, was convened in November 2009 to consider the evidence for non-LDL lipids as risk factors for cardiovascular disease.
The Panel is co-chaired by Professor John Chapman, France, and Professor Henry Ginsberg, USA.
Familial Hypercholesterolaemia in Children and Adolescents :: Statin-associated muscle symptoms (SAMS) :: Homozygous familial hypercholesterolaemia :: The polygenic nature of hypertriglyceridaemia :: Plant sterols and plant stanols :: Familial hypercholesterolaemia is underdiagnosed and undertreated :: Triglyceride-rich lipoproteins :: Lipoprotein(a) as a cardiovascular risk factor :: ESC/EAS on PCSK9
In an expert panel together with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM), EAS is working on recommendations for laboratory testing of lipids and cardiovascular risk markers.
Fasting is not routinely required for determination of a lipid profile: Clinical and laboratory implications including flagging at desirable concentration cut-points. A joint consensus statement from the EAS and EFLM
01/09/2016 » 13/02/2017
Early registration to the 85th EAS congress April 23-26, 2017 Prague, Czech Republic
01/12/2016 » 01/02/2017
Open for nominations: Young Investigator Awards for outstanding publications 2016